Aarcaresearch
Aarca Research Pvt Ltd is a healthtech company. Our product IHRA (Intelligent Health Risk Assessment) is a first-of-its-kind diagnostic method for the risk evaluation of Type 2 Diabetes, Hypertension and Dyslipidemia.
Preventive healthcare solutions by Aarca Research. Rising cases of the COVID-19 epidemic even after years have made all of us realize for the first time after the industrial revolution how unprepared we are when a significant health calamity occurs.
And the solution for this was in a simple “wearing mask” pronouncing prevention is better than cure, and we as an individual can avert socio-economic burden by doing this simple act. WHO has identified Non-communicable diseases NCDs as the next big epidemic. Are we prepared for it? Preventive healthcare means the efforts that are taken to prevent diseases rather than spending our resources on only treating them. An individual is advised to go for regular health check-ups even if the person is healthy as lifestyle diseases are often asymptomatic.
The global preventive healthcare market is estimated to reach $432 billion by 2025, growing at 9.5% CAGR with early-detection and screening technologies being the main contributors to this growth. The beginner's guide to preventive healthcare assessments. Every decade a person ages, the risk of developing non-communicable deceases like Type 2 Diabetes and Hypertension doubles.
Screening and early detection of diseases through preventive tests not only save a life but also protects an individual and her family from going through immense physical, emotional, and financial distress. By preventing these conditions, or identifying them early, you are more likely to live a longer, healthier, and more satisfying life. So what qualifies as preventive health services? Many healthcare professionals follow guidelines from the U.S. Preventive Services Task Force. The following preventive services are vital for consideration: Annual wellness exam: Visit your healthcare professional once a year for a physical.
Type 2 Diabetes screening: Type 2 Diabetes is a metabolic disease that is becoming very common with changing lifestyles habits. High Blood Pressure Screening: Risk of developing high blood pressure increases as you get older. The non- Invasive way to conduct Health Risk Assessment screenings - Aarca Research. Health Risk Assessment screening is an essential and useful way to keep track of one’s health.
Employer or an insurance company may offer a yearly health screening assessment to check general fitness as a health and wellness perks. Frequently Asked Questions (FAQs) - IHRA Screening. Increasing interest in the field of metabolic disorders and an increase in related diseases has resulted in a demand for prognostic procedures which can be used for screening purposes to decide which patient cases should be further investigated.
Thermography, which combines a high degree of accuracy with complete safety, meets the need. Thermography involves the detection of heat energy by an infrared-sensitive device, with subsequent conversion to electrical energy, amplification, and a suitable means of display. As the heat emitted from the skin which has an emissivity of 0.98 is related to blood flow. Measurement of the heat emission gives a measure of blood flow. Our non-invasive, non-contact method of infrared thermal imaging is a new diagnostic modality for diagnosing Type 2 Diabetes, Hypertension, and Dyslipidaemia. Publications & Case Studies - Non-Invasive Diagnostics. Partners Login - Launch A Preventive Healthcare Tool. Aarca Research: Risk-assessment for Type 2 Diabetes and Hypertension.
Ihra - Aarca Research. IHRA - Intelligent Health Risk Assessment IHRA is a single touchpoint, easy to use, portable solution for preventive healthcare screenings.
It provides individual comorbidity evaluation report for chronic diseases like Type 2 Diabetes and Hypertension. Our software uses an IR radiation-based, passive video as input, which is free of any harmful radiation and provides a risk evaluation score as IMRI (Individual Morbidity Risk Index) on a scale of ten (where zero is normal and 10 is high risk) for Type 2 diabetes, Hypertension and Dyslipidemia. We further categorise the risk to very low, low, medium, and high based on the score.
Our algorithms use thermal pattern values to calculate the observed variance related to atherosclerosis, and hemodynamics, which works as a biomarker to identify the condition and its severity. If you are a healthcare facility or a diagnostic facility or an NGO conducting a camp or a corporate interested in improving your employees' health, IHRA is your solution! Aarca Research - Healthcare Diagnostics. Aarca Research - A HealthTech company.